Sector: MedicalTRUBION PHARMACEUTIC (NASDAQ: TRBN)
Headlines
- Trubion Pharmaceuticals, Inc. Announces Transition in Company Leadership
Nov 16, 2009 04:00 PM | TRBN
- Trubion Announces Acceptance of Two Presentations on Its TRU-016 Product Candidate at the 2009 ASH Annual Meeting
Nov 11, 2009 04:00 PM | FACT, TRBN
- Trubion Pharmaceuticals, Inc. Reports Third Quarter and Nine Months 2009 Financial Results
Nov 05, 2009 04:01 PM | FACT, PFE, TRBN
- Trubion Announces Dates for Third Quarter and Nine Months 2009 Earnings Conference Call
Oct 29, 2009 04:00 PM | TRBN
- Trubion Announces Upcoming Presentation at 8th Annual BIO Investor Forum
Oct 26, 2009 04:00 PM | TRBN
- Trubion Pharmaceuticals, Inc. Reports Positive Data from Phase 2b Re-treatment Study of TRU-015
Oct 19, 2009 08:25 AM | PFE, TRBN
- Trubion Pharmaceuticals, Inc. to Present at the Morgan Stanley Global Healthcare Conference
Sep 08, 2009 04:00 PM | MS, TRBN
- Facet Biotech and Trubion Announce Worldwide Collaboration for the Development and Commercialization of TRU-016
Aug 28, 2009 08:00 AM | FACT, TRBN
- Trubion Pharma: Wyeth Begins Patient Dosing In TRU-015 Trial
May 07, 2008 05:17 PM | TRBN, WYE
- Trubion Says Wyeth Initiates Phase I Study Of SBI-087
Apr 21, 2008 05:07 PM | TRBN, WYE
- Trubion Pharmaceuticals Inc. Reports Second Quarter and First Half 2009 Financial Results
Aug 06, 2009 04:00 PM | TRBN
- Trubion Announces Dates for Second Quarter and First Half 2009 Earnings Conference Call
Jul 30, 2009 04:01 PM | TRBN
- Trubion Pharmaceuticals Announces Extension of Research Period Under Its Wyeth Collaboration
Jun 22, 2009 04:00 PM | TRBN, WYE
- Trubion to Present at the 8th Annual Needham Life Sciences Conference
Jun 04, 2009 04:00 PM | TRBN
- Trubion Announces Positive Data From a Phase 1 / 2 Study of TRU-016 for the Treatment of Chronic Lymphocytic Leukemia (CLL)
Jun 01, 2009 07:01 AM | TRBN
- Trubion Pharmaceuticals, Inc. to Present Positive Data From a Phase 2b Re-treatment Study of TRU-015 at the 2009 EULAR Annual Meeting
May 18, 2009 04:29 PM | TRBN
- Trubion Announces Acceptance of Three Presentations on Its TRU-016 Product Candidate at the 2009 ASCO Annual Meeting
May 14, 2009 06:00 PM | TRBN
- Trubion Pharmaceuticals, Inc. Reports First-Quarter 2009 Financial Results
May 07, 2009 04:01 PM | TRBN
- Trubion Announces Dates for First-Quarter 2009 Earnings Conference Call
Apr 30, 2009 04:01 PM | TRBN
- Trubion Pharmaceuticals, Inc. Announces Upcoming Presentation at the 2009 American Association of Cancer Research Annual Meeting
Apr 16, 2009 04:01 PM | TRBN
- Form 3 Trubion Pharmaceuticals, For: Nov 16 Filed by: Bencich John (10K)
Nov 19, 2009 05:29 PM
- Form 4 Trubion Pharmaceuticals, For: Nov 16 Filed by: GILLIS STEVEN (10K)
Nov 17, 2009 04:50 PM
- Form 3 Trubion Pharmaceuticals, For: Sep 01 Filed by: FACET BIOTECH CORP (10K)
Sep 03, 2009 01:41 PM
- Form 4 Thompson Peter A For: Aug 27 (10K)
Aug 28, 2009 05:47 PM
- Form 4 STROMATT SCOTT For: Aug 27 (10K)
Aug 28, 2009 05:46 PM
- Form 4 Mohler Kendall For: Aug 27 (10K)
Aug 28, 2009 05:41 PM
- Form 4 MCKEREGHAN KATHLEEN For: Aug 27 (10K)
Aug 28, 2009 05:41 PM
- Form 4 BURRIS MICHELLE For: Aug 27 (10K)
Aug 28, 2009 05:40 PM
- Form 4 SCHNELL DAVID For: May 27 (10K)
May 28, 2009 07:14 PM
- Form 4 Saks Samuel R For: May 27 (10K)
May 28, 2009 07:13 PM
Analyst Ratings
Sentiment Survey
|
|
|
|
|
|
|
|
|
|
|
Share Performance
|
Period
|
TRBN
|
Compare to S&P
|
| YTD |
185.16 %
|
135.98 %
|
| 4 Weeks |
-16.28 %
|
-20.53 %
|
| 12 Weeks |
-33.39 %
|
-37.98 %
|
|
Financial Ratios
Earnings Performance
|
EPS Growth in Last Quarter: 10.81 %
|
|
EPS Growth in Last Year: 10.81 %
|
|
Sales Growth in Last Quarter: 8.08 %
|
|
Sales Growth in Last Quarter: 18.22 %
|
|
